(Q73520468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Arie Ben-Yehuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Aviva Joseph

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Yechezkel Barenholz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Evelyne Zeira

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Simcha Even-Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Igal Louria-Hayon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ilan Babai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Zichria Zakay-Rones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Evgenia Greenbaum

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Ilia Galprin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Reinhard Glück

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Rinaldo Zurbriggen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Eli Kedar

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

3169-3178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

Impact of epidemic type A influenza in a defined adult population

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

The aging immune system: primer and prospectus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Cytokine-containing liposomes as adjuvants for HIV subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

A short human and mouse MLR assay utilizing lymphokine (IL-2, IL-3) secretion as an early activation event

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Determination of total protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Immunogenicity of new virosome influenza vaccine in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

The lectin neuraminidase inhibition test: a new method for the detection of antibodies to neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Biodegradable microspheres containing influenza A vaccine: immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Immunoadjuvant activity of interferon-gamma-liposomes co-administered with influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Adjuvant effect of low-dose interleukin-2 on antibody response to influenza virus vaccination in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Programmed antigenic stimulation: kinetics of the immune response to challenge infections of mice primed with influenza inactivated whole virus or neuraminidase vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Protection against lethal influenza with neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

The antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900251-2

7 January 2021

10.1016/S0264-410X(03)00251-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12804845%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference